Anne Fung

Perceive Biotherapeutics is a South San Francisco-based biotechnology company focused on developing transformative therapies for blinding diseases, particularly retinal degenerations. The company leverages a proprietary platform based on "protective biology" and deep genetic insights to identify targets that can prevent vision loss. Its lead programs target dry age-related macular degeneration (AMD) and glaucoma, utilizing modalities such as gene therapy. Led by a team of industry veterans, including CEO K. Angela Macfarlane and CMO Dr. Anne Fung, Perceive Bio aims to address the high unmet need in ophthalmology by protecting retinal cells from degeneration.